J. Soulier

发表

New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptors.

M. Langlois, D. Yang, J. Soulier, 1997, Journal of medicinal chemistry.

Design and synthesis of specific probes for human 5-HT4 receptor dimerization studies.

B. Maigret, F. Lezoualc’h, R. Fischmeister, 2005, Journal of medicinal chemistry.

Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's disease.

F. Lezoualc’h, T. Richard, J. Monti, 2009, Journal of medicinal chemistry.

Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors.

M. Langlois, J. Soulier, S. Sicsic, 2003, Journal of medicinal chemistry.

New arylpiperazine derivatives as antagonists of the human cloned 5-HT(4) receptor isoforms.

F. Lezoualc’h, R. Fischmeister, M. Langlois, 2000, Journal of medicinal chemistry.

Introduction of polar groups on the naphthalene scaffold of molecular tongs inhibiting wild-type and mutated HIV-1 protease dimerization

R. Fanelli, N. Tonali, J. Soulier, 2014 .

Carbonylhydrazide-based molecular tongs inhibit wild-type and mutated HIV-1 protease dimerization.

R. Fanelli, B. Crousse, J. Soulier, 2012, Journal of medicinal chemistry.

Structural analysis of 5-HT3 receptor antagonists: synthesis and pharmacological activity of various aromatic esters or amides derived from tropane and 1,2,6-trisubstituted piperidine

M. Langlois, D. Yang, J. Soulier, 1993 .

Synthesis of quinazoline-2,4-dione and naphthalimide derivatives as new 5-HT3 receptor antagonists

M. Langlois, D. Yang, J. Soulier, 1994 .

Towards a general synthesis of di-aza-amino acids containing peptides

B. Crousse, N. Tonali, J. Soulier, 2018 .

The use of 4,4,4-trifluorothreonine to stabilize extended peptide structures and mimic β-strands

T. Ha-Duong, O. Lequin, B. Crousse, 2017, Beilstein journal of organic chemistry.

Designed Glycopeptidomimetics Disrupt Protein-Protein Interactions Mediating Amyloid β-Peptide Aggregation and Restore Neuroblastoma Cell Viability.

D. Allsop, M. Taylor, O. Lequin, 2016, Journal of medicinal chemistry.

Structure-activity relationships of sugar-based peptidomimetics as modulators of amyloid β-peptide early oligomerization and fibrillization.

O. Lequin, M. Taverna, B. Crousse, 2014, European journal of medicinal chemistry.

Sugar-based peptidomimetics inhibit amyloid β-peptide aggregation.

O. Lequin, J. Soulier, Isabelle Correia, 2011, European journal of medicinal chemistry.

Toward the First Nonpeptidic Molecular Tong Inhibitor of Wild‐Type and Mutated HIV‐1 Protease Dimerization

L. Bannwarth, J. Soulier, S. Sicsic, 2010, ChemMedChem.

Structure-activity relationships of β-hairpin mimics as modulators of amyloid β-peptide aggregation.

T. Ha-Duong, C. van Heijenoort, M. Taverna, 2018, European journal of medicinal chemistry.

A New electrochemical access to unsymmetrical γdiketones via the corresponding γbisdioxolanes. Application to the synthesis of dihydrojasmone

J. Soulier, D. Lelandais, Cathy Bacquet-Einhorn, 2010 .

Neonatal neuroblastoma and in utero exposure to progestagens

A. Sasco, J. Soulier, D. Satgé, 1998 .

Arylcarbamate derivatives of 1-piperidineethanol as potent ligands for 5-HT4 receptors.

M. Langlois, D. Yang, J. Soulier, 1997, Journal of medicinal chemistry.

α- and β-hydrazino acid-based pseudopeptides inhibit the chymotrypsin-like activity of the eukaryotic 20S proteasome.

Nathalie Lagarde, B. Crousse, J. Soulier, 2013, European journal of medicinal chemistry.

Derivatives of quinuclidine as 5-HT3 receptor antagonists: influence of an additional carbonyl group on the recognition of chirality by the receptor.

M. Langlois, J. Soulier, C. Gallais, 1993 .

New insights into the human 5‐HT4 receptor binding site: exploration of a hydrophobic pocket

Frank Lezoualc'h, Rodolphe Fischmeister, Bernard Maigret, 2004, British journal of pharmacology.

Designed Glycopeptidomimetics Disrupt Protein-Protein Interactions Mediating Amyloid β-Peptide Aggregation and Restore Neuroblastoma Cell Viability.

D. Allsop, M. Taylor, O. Lequin, 2016, Journal of medicinal chemistry.

Synthesis of specific bivalent probes that functionally interact with 5-HT(4) receptor dimers.

F. Lezoualc’h, R. Jockers, J. Soulier, 2007, Journal of Medicinal Chemistry.

N-chloromethyl quinuclidinium derivatives: A new class of irreversible ligands for 5-HT3 receptors.

M. Langlois, J. Soulier, M. Mathé-Allainmat, 1994 .